SINOPHARM applies to sell COVID-19 vaccines SINOPHARM applies to sell COVID-19 vaccines. China SINOPHARM (China National Pharmaceutical Group Co., Ltd.)...
Vaccines
Chinese COVID-19 vaccines enters Phase III clinical trials in Turkey Chinese COVID-19 vaccines enters Phase III clinical trials in Turkey....
Vaccine Management Experience in China Vaccine Management Experience in China. Vaccines are one of the most effective and economical means...
COVID-19 Vaccines will be launched in China in early 2021 COVID-19 Vaccines will be launched in China in early 2021....
AstraZeneca: COVID-19 vaccines will reach 3 billion in 2021 AstraZeneca: COVID-19 vaccines will reach 3 billion in 2021. On November...
AstraZeneca's COVID-19 Vaccine AZD1222 Trial Results AstraZeneca's COVID-19 Vaccine AZD1222 Trial Results. Two different dosage regimens, one of which is...
AstraZeneca's COVID-19 vaccine 70% effective AstraZeneca's COVID-19 vaccine 70% effective. AstraZeneca's COVID-19 vaccine has an average effectiveness of 70%, which...
A COVID-19 vaccine from China long stable at 2 to 8 °C A COVID-19 vaccine from China CanSinoBio long stable...
China summarizes COVID-19 vaccines development China summarizes COVID-19 vaccines development. The Ministry of Foreign Affairs of China summarizes China's COVID-19...
SINOPHARM COVID-19 vaccines better than expected SINOPHARM COVID-19 vaccines are better than expected! A number of foreign politicians vigorously supported...
